epiH Search

CLOSE



Epidemiol Health > Accepted Articles
Epidemiology and Health 2022;e2022072.
DOI: https://doi.org/10.4178/epih.e2022072    [Accepted] Published online Sep 7, 2022.
Effect of Pap Smear on the Long-term Survival of Cervical Cancer Patients: A Nationwide Population-based Cohort Study
Xuan Quy Luu1  , Kyeongmin Lee1  , Jae Kwan Jun2  , Mina Suh3  , kyu-won Jung2  , Myong Cheol Lim4  , Kui Son Choi1 
1Graduate School of Cancer Science and Policy, National Cancer Center , Gyeonggi-do , Korea
2National Cancer Control Institute, National Cancer Center, Goyang-si, Korea
3National Cancer Control Institute, National Cancer Center, Goyang-si, Korea
4Research Institute and Hospital, National Cancer Center, Goyang-si, Korea
Correspondence  Kui Son Choi ,Email: kschoi@ncc.re.kr
Received: Jun 29, 2022  Accepted after revision: Sep 7, 2022
Abstract
Objectives:
This study aims to investigate the effect of cervical cancer screening by pap smear on the long-term survival of cervical cancer patients.
Method:
We constructed a retrospective cohort of 14,903 women diagnosed with invasive cancer or carcinoma in situ (CIS) in 2008 and 2009 and followed up until December 31, 2019, by using individual-level data from three national databases of the Korean National Cancer Screening Program, the Korean Central Cancer Registry, and death certificates. Cox proportional-hazards regression was used to investigate the effect of cervical cancer screening on mortality.
Results:
A total of 12,987/14,867 patients (87.4%) were alive at the end of the follow-up period (median: 10.5 years). Screened patients had a 38% lower risk of cervical cancer death than never-screened patients (hazard ratio [HR]=0.62; 95% confidence interval [CI], 0.54–0.70). The risk of death from cervical cancer decreased by 59% and 35%, respectively, in screened patients with localized and regional stages. Further, a lower HR was observed in all age groups, especially women aged 50–59 years (HR=0.54; 95% CI, 0.42–0.69). The lowest HR for cervical cancer death was reported among patients screened within the past two years (HR=0.54; 95% CI=0.47–0.63), following which the HRs increased with increasing time intervals.
Conclusions:
Pap smear screening significantly reduces the risk of cervical cancer-specific death in Korean women across all cancer stages.
Keywords: Cervical cancer; Papanicolaou test; Mass screening; Survival


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
FOR AUTHORS AND REVIEWERS
Editorial Office
Department of Preventive Medicine, Yonsei University College of Medicine
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
TEL: +82-2-745-0662   FAX: +82-2-764-8328    E-mail: office.epih@gmail.com

Copyright © 2022 by Korean Society of Epidemiology.

Developed in M2PI

Close layer
prev next